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Development of an immunoassay for ciprofloxacin 
using phage-displayed antibody fragments
Ciprofloxacin (CPFX), one of the most widely prescribed antibiotic [1], is a large spectrum synthetic drug of the fluoroquinolone’s group. Because of its impact on 
health and environment, the EU has set a regulatory residual limit of 30 µg kg–1 for CPFX in edible animal tissues [2]. Therefore, ultra sensitive methods of 
detection and quantification need to be developed. CPFX is commonly determined by chromatographic procedures, namely HPLC and GC, but these techniques 
are laborious and time demanding. We report the isolation of phage-displayed antibody fragments (phAbs) against CPFX from a semi-synthetic phagemid library 






Wash with 4x PBST, 4x PBS 
Removal of non-specific phAbs
3. Elution
Incubation of bound phAbs with excess CPFX 
(competition)
• 1st and 2nd rounds with 250 mM CPFX
• 3rd round with 25 mM CPFX
• 4th round with 100 µM CPFX
4. Gel filtration
Separation of CPFX from eluted 
phAbs, (in order to prevent 
bacterial death in next step)
5. Infection








2. Selection by Phage Display
3. Magnetic Beads-ELISA
All five positive monoclonal phAbs will be tested to determine their ability to bind free CPFX (and other fluoroquinolones) by competitive elution. Selected ones will be 
used to produce soluble and purified VH fragments. Their affinity constants will be estimated by competitive ELISA. Also, their ability to bind similar molecules will be 
evaluated. One or more VH fragments will be used in immunoassays to determine and quantify CPFX on environmental samples.
Five positive monoclonal antibodies-fragments against CPFX were efficiently 
isolated from a semi-synthetic phage antibody library by panning against 
immobilized CPFX on magnetic beads. PCR and RFLP analyses showed that 
isolated clones were VH fragments. ELISA testing demonstrated affinity towards 
CPFX.
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1. CPFX immobilization on magnetic beads
In order to determine the content of CPFX-binding phAbs in samples, an ELISA using CPFX-magnetic beads was 
developed.
• Blocking of beads with soy proteins.
• Incubation of phAbs solution (approx,1010 phAbs) with 50 µg beads-CPFX, 2h, RT.
• Washing with PBST + PBS.
• Detection of bound phAbs using Anti-M13-HRP, 2h.
• Washing with PBST + PBS.
• Color development with ABTS solution for 30 min. 
• Transfer to an ELISA plate and reading of OD at 405 nm.
CPFX was efficiently immobilized onto amine-
derivatized magnetic beads using EDC (figure 1). 
Coupling efficiency was determined by quantification of 
unreacted CPFX by HPLC-UV. 
Using a molar excess of 1.3x CPFX, all amine 
groups were bound to ciprofloxacin. Under these 
conditions 1 µg of beads suspension corresponds to 
about  2.5 nmol immobilized CPFX.
Enrichment of positive polyclonal phAbs against 
CPFX was confirmed by magnetic-beads ELISA. 
ELISA signal increased after each round.
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RFLP of individual amplified VH fragments from the 4th round was 
performed by digestion with the BstNI restriction enzyme.
It was observed that there were 5 different phAbs, while 2 were 
identical (clones C and D). 
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Table 1 - Results of immobilization assays. Percentage of CPFX unreacted was determined by 
HPLC-UV.
Figure 5 - PCR amplification using LMB3 and FdSeq1 primers of antibody fragment genes from individual ampicillin-resistant clones 
isolated from 4th round. The expected size of the PCR products was about 1000 bp (scFv). Interestingly, all are about 500 bp, 
suggesting display of a VH fragment (See figure 4)
500 bp
Eight PCR positive monoclonal phAbs were tested by ELISA in 
order to identify CPFX binding ones.
Six were positive to CPFX while 2 were negative. A control 
was performed with phAbs specific to one other ligand.
Figure 2 - Schematic representation of selection of antibody fragments against CPFX by phage display
Figure 3 - Magnetic beads ELISA of polyclonal phAbs obtained 
from library to 4th round. Control was with any phAbs.
Figure 4 - Schematic representation of the phagemid pHEN2 from 
the synthetic library [3]. 
1. Selection
Ratio CPFX/Beads 





0.5 10 53 
0.9 9 82 
1.1 16 94 
1.3 12 100 
2.5 58 100 
 
The PCR results indicate 
that all antibody fragments’ 
genes ampli f ied from 
individual clones obtained 




Figure 6 - Magnetic bead ELISA of monoclonal phAbs isolated 
from the 4th round
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Figure 1 - Reaction scheme of immobilization of CPFX onto magnetic beads by the activation of carboxylic groups on CPFX with carbodiimide (EDC) and then
the formation of an ester linkage to amine groups on magnetic beads
Incubation of 1010 phages displaying
different antibody fragments [3] with
50 µg magnetic beads-CPFX
